204 related articles for article (PubMed ID: 22733136)
1. SUMO-specific protease 1 promotes prostate cancer progression and metastasis.
Wang Q; Xia N; Li T; Xu Y; Zou Y; Zuo Y; Fan Q; Bawa-Khalfe T; Yeh ET; Cheng J
Oncogene; 2013 May; 32(19):2493-8. PubMed ID: 22733136
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
3. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.
Bawa-Khalfe T; Cheng J; Lin SH; Ittmann MM; Yeh ET
J Biol Chem; 2010 Aug; 285(33):25859-66. PubMed ID: 20551310
[TBL] [Abstract][Full Text] [Related]
4. Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.
Wang C; Tao W; Ni S; Chen Q; Zhao Z; Ma L; Fu Y; Jiao Z
Cancer Sci; 2015 Apr; 106(4):375-82. PubMed ID: 25645686
[TBL] [Abstract][Full Text] [Related]
5. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
[TBL] [Abstract][Full Text] [Related]
6. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.
Xu Y; Li J; Zuo Y; Deng J; Wang LS; Chen GQ
Cancer Lett; 2011 Oct; 309(1):78-84. PubMed ID: 21669491
[TBL] [Abstract][Full Text] [Related]
7. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells.
Wang C; Tao W; Ni S; Chen Q
Int J Biol Sci; 2019; 15(2):395-403. PubMed ID: 30745829
[No Abstract] [Full Text] [Related]
8. SUMO-specific protease 1 modulates cadmium-augmented transcriptional activity of androgen receptor (AR) by reversing AR SUMOylation.
Wu R; Cui Y; Yuan X; Yuan H; Wang Y; He J; Zhao J; Peng S
Toxicol Lett; 2014 Sep; 229(2):405-13. PubMed ID: 25014244
[TBL] [Abstract][Full Text] [Related]
9. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
10. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
[TBL] [Abstract][Full Text] [Related]
11. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway.
Gu J; Fan Y; Liu X; Zhou L; Cheng J; Cai R; Xue S
Cardiovasc Res; 2014 Oct; 104(1):83-92. PubMed ID: 25082844
[TBL] [Abstract][Full Text] [Related]
12. Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance.
Monet M; Lehen'kyi V; Gackiere F; Firlej V; Vandenberghe M; Roudbaraki M; Gkika D; Pourtier A; Bidaux G; Slomianny C; Delcourt P; Rassendren F; Bergerat JP; Ceraline J; Cabon F; Humez S; Prevarskaya N
Cancer Res; 2010 Feb; 70(3):1225-35. PubMed ID: 20103638
[TBL] [Abstract][Full Text] [Related]
13. Role of desumoylation in the development of prostate cancer.
Cheng J; Bawa T; Lee P; Gong L; Yeh ET
Neoplasia; 2006 Aug; 8(8):667-76. PubMed ID: 16925949
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.
Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR
Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808
[TBL] [Abstract][Full Text] [Related]
15. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
16. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.
Agoulnik IU; Vaid A; Bingman WE; Erdeme H; Frolov A; Smith CL; Ayala G; Ittmann MM; Weigel NL
Cancer Res; 2005 Sep; 65(17):7959-67. PubMed ID: 16140968
[TBL] [Abstract][Full Text] [Related]
17. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
Ao Q; Su W; Guo S; Cai L; Huang L
Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
[TBL] [Abstract][Full Text] [Related]
18. Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Wu J; Lei H; Zhang J; Chen X; Tang C; Wang W; Xu H; Xiao W; Gu W; Wu Y
Oncotarget; 2016 Sep; 7(37):58995-59005. PubMed ID: 27449295
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome.
Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T
Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059
[TBL] [Abstract][Full Text] [Related]
20. Induction of the SUMO-specific protease 1 transcription by the androgen receptor in prostate cancer cells.
Bawa-Khalfe T; Cheng J; Wang Z; Yeh ET
J Biol Chem; 2007 Dec; 282(52):37341-9. PubMed ID: 17932034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]